A Meta-Analysis of Folic Acid in Combination with Anti-Hypertension Drugs in Patients with Hypertension and Hyperhomocysteinemia

por Wang, Wen-Wen, Wang, Xin-Shi, Zhang, Zeng-Rui, He, Jin-Cai, Xie, Cheng-Long
Publicado 2017

Neuroprotective properties of curcumin in toxin-base animal models of Parkinson’s disease: a systematic experiment literatures review

por Wang, Xin-Shi, Zhang, Zeng-Rui, Zhang, Man-Man, Sun, Miao-Xuan, Wang, Wen-Wen, Xie, Cheng-Long
Publicado 2017

A Meta-Analysis of Adenosine A2A Receptor Antagonists on Levodopa-Induced Dyskinesia In Vivo

por Wang, Wen-Wen, Zhang, Man-Man, Zhang, Xing-Ru, Zhang, Zeng-Rui, Chen, Jie, Feng, Liang, Xie, Cheng-Long
Publicado 2017

Effects of mGluR5 Antagonists on Parkinson's Patients With L-Dopa-Induced Dyskinesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

por Wang, Wen-Wen, Zhang, Xing-Ru, Zhang, Zeng-Rui, Wang, Xin-Shi, Chen, Jie, Chen, Si-Yan, Xie, Cheng-Long
Publicado 2018

Levodopa/Benserazide PLGA Microsphere Prevents L-Dopa–Induced Dyskinesia via Lower β-Arrestin2 in 6-Hydroxydopamine Parkinson’s Rats

por Wang, Wen-Wen, Zhang, Xing-Ru, Lin, Jing-Ya, Zhang, Zeng-Rui, Wang, Zhen, Chen, Si-Yan, Xie, Cheng-Long
Publicado 2019

The Advantages of Levodopa-Carbidopa Intestinal Gel for Patients with Advanced Parkinson’s Disease: A Systematic Review

por Zhang, Xing-Ru, Jiang, Zhi-Yu, Zhang, Zeng-Rui, Chen, Hui-Jun, Wu, Ke, He, Jin-Cai, Xie, Cheng-Long
Publicado 2020

β-arrestin2 alleviates L-dopa–induced dyskinesia via lower D1R activity in Parkinson’s rats

por Zhang, Xing-Ru, Zhang, Zeng-Rui, Chen, Si-Yan, Wang, Wen-Wen, Wang, Xin-Shi, He, Jin-Cai, Xie, Cheng-Long
Publicado 2019

Role of sLOX‐1 in intracranial artery stenosis and in predicting long‐term prognosis of acute ischemic stroke

por Li, Xian‐Mei, Jin, Ping‐Ping, Xue, Jie, Chen, Jie, Chen, Qin‐Fen, Luan, Xiao‐Qian, Zhang, Zeng‐Rui, Yu, Tie‐Er, Cai, Zheng‐Yi, Zhao, Kai, Shao, Bei
Publicado 2017